0
Article   |    
ACTION OF METHYL-PHENIDYLACETATE (RITALIN) AND RESERPINE IN BEHAVIOR DISORDERS IN CHILDREN AND ADULTS
FREDERIC T. ZIMMERMAN; BESSIE B. BURGEMEISTER
Am J Psychiatry 1958;115:323-328.
View Article Information
The College of Physicians and Surgeons, Columbia University, and the Division of Child Neurology, the Neurological Institute of New York.
text A A A
PDF of the full text article.
Abstract
1. Results of the present study show no significant improvement in verbal intelligence re-test quotient following 6 months of treatment with Ritalin or reserpine, during a time when behavioral improvement was noted in almost two-thirds of two matched groups of children with severe behavioral disorders.2. Results of motor test favor patients treated with Ritalin, reduction in reaction time being much larger for all sub-test items on re-test than for the reserpine group where no essential change is recorded. In-asmuch as reaction time is one of the most objective and accurate measures of stimulation, increased speed of reaction under Ritalin is a significant finding.3. Group findings agree with those of other investigators in showing that Ritalin is more effective than reserpine in alleviating depression, increasing alertness, lessening listlessness, etc., the most favorable results being noted where these pre-treatment symptoms were present. Overlapping between the action of both drugs was noted in all behavioral categories following therapy, making interpretation difficult in Individual cases as to the drug of choice.4. Toxic signs were infrequent and mild, treatment with Ritalin causing occasional insomnia, hyperactivity, loss of appetite, etc., on large doses, especially in children under 6 years of age, but no serious untoward side reactions were seen in any of the patients treated. Drowsiness constituted the major toxic sign in reserpine therapy.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Books
    The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 36.  >
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 2.  >
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 3.  >
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 4.  >
    Topic Collections
    Psychiatric News
    APA Guidelines
    PubMed Articles